Adaptive Biotechnologies Corp

Maps immune genetics for blood cancer diagnostics and drug discovery partnerships.

ADPT | NDAQ

Overview

Corporate Details

ISIN(s):: US00650F1093
LEI:
Country:: United States of America
Address:: 1165 EASTLAKE AVE E, 98109 SEATTLE
Website:: https://www.adaptivebiotech.com
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Adaptive Biotechnologies is a commercial-stage biotechnology company pioneering the field of immune medicine. The company's proprietary Immune Medicine Platform maps the genetics of the adaptive immune system by sequencing T-cell and B-cell receptors at scale. This technology enables two primary application areas: clinical diagnostics and drug discovery. Its key diagnostic product is a highly sensitive, next-generation sequencing (NGS)-based assay for the assessment of Minimal Residual Disease (MRD) in blood cancers, used in both clinical practice and drug trials. Additionally, Adaptive partners with pharmaceutical companies, providing rich immune receptor data and services to inform clinical trials and support the development of new therapeutics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Adaptive Biotechnologies Corp filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Adaptive Biotechnologies Corp

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Adaptive Biotechnologies Corp via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
FTAI Infrastructure Inc. Develops, acquires, and operates critical infrastructure in rail, ports, power, and gas.	United States of America	FIP
FunPep Company Limited Biotech firm developing peptide-based therapeutics, cosmetics, and medical devices.	Japan	4881
Gain Therapeutics, Inc. Using an AI platform to develop allosteric therapies for neurodegenerative diseases.	United States of America	GANX
GALAPAGOS NV Developing a rapid, decentralized cell therapy platform for oncology and immunology.	United States of America	GLPG
Galaxy Payroll Group Ltd APAC cross-border payroll, EOR, and corporate services for global businesses.	United States of America	GLXG
GATX CORP Global lessor of railcars, locomotives, and spare aircraft engines for key industries.	United States of America	GATX
GECOSS CORPORATION Leases and sells temporary steel materials and equipment for large construction projects.	Japan	9991
GENDAI AGENCY INC. Advertising agency providing marketing and promotions for the pachinko industry.	Japan	2411
Geneuro Developing antibody therapies targeting pathogenic HERVs for MS and post-COVID syndromes.	Switzerland	GEM
Genexine, Inc. Developing long-acting immunotherapeutics for immuno-oncology and rare diseases.	South Korea	095700